| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8817915 | Health Policy | 2018 | 7 Pages |
Abstract
There is a need for further improvement in accessibility of orphan drugs in the Balkan countries. Cross-border collaboration in the field of pricing, health technology assessment, and reimbursement negotiation of orphan drugs may help to address these challenges.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Ana V. Pejcic, Georgi Iskrov, Mihajlo Michael Jakovljevic, Rumen Stefanov,